ANI Pharmaceuticals | ANIP - Pre Tax Profit


ANI Pharmaceuticals reported $49.52M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 2.67B 1.71B Dec/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Assertio Holdings USD -2.88M 648K Sep/2024
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Canopy Growth CAD -62.26M 60.84M Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Novartis USD 5.17B 637M Sep/2025
Omeros USD -65.12M 21.27M Jun/2024
Perrigo USD 22.4M 19.2M Sep/2025
Sun Pharmaceuticals INR 41.68B 9.95B Sep/2025
Teva Pharmaceutical Industries USD 753M 662M Mar/2026